Verve Therapeutics
About Us
Why Heart Disease
Approach
Culture & Careers
News
Contact Us
Verve banks $63M to move gene-editing heart attack treatment toward clinic
Post navigation
Previous Post
Previous
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes
Next Post
Next
Verve Therapeutics to Take On Heart Disease With $63 Million Funding Round
Home
About Us
Why Heart Disease
Approach
Culture & Careers
News
Contact Us